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Accepted 19 April 2013Pulmonary embolism (PE) is deﬁned as the obstruction of the
main arteries of the lung by a substance (such as thrombus, fat, or
amniotic ﬂuid) that has traveled through the bloodstream. PE re-
mains a leading cause of maternal mortality in the United States [1].
It is a rare, unpredictable, and unpreventable life-threatening
complication of pregnancy, with incidence rates ranging from
0.11 to 0.73 per 1000 deliveries [2].
Because the maternal hypercoagulable state is part of a normal
physiological preparation for delivery, hypercoagulability during
pregnancy is associated with a 5-fold increased risk in venous
thromboembolism [3]. Early detection of thromboembolism during
pregnancy or during the postpartum period enables identiﬁcation
of patients who require anticoagulant treatment.
According to the International Cooperative Pulmonary Embo-
lism Registry, the death rate from massive PE among hemody-
namically unstable patients is 52% [4]. In this report, we describe a
case in which massive PE developed 2 days after the cesarean
section; the patient was successfully treated with early application
of the extracorporeal membrane oxygenation (ECMO) system,
catheter-directed thrombectomy, and anticoagulants. We further
describe the use of the ECMO system as a bridge therapy to support
patients through the diagnostic workup for suspected PE and
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1028-4559/Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. PublishedA 37-year-old woman (G2P1) at a gestational age of 37 weeks
and 2 days with P1 through natural spontaneous delivery pre-
sented with symptoms of labor. Upon arriving at our ward, the
patient showed a cervix dilatation of 5 cm. A cardiotocogram
revealed regular uterine contraction at intervals between 4minutes
and 10 minutes. No signs of infection were evident and laboratory
tests were within normal limits.
During labor, a nonreassuring fetal heart rate was noted and an
emergent cesarean delivery was performed. After the surgery, the
patient had bed rest for 2 days because of bilateral lower-limb
weakness. Consciousness disturbance with weakness in all four
limbs suddenly developed after mobilization on postoperative Day
3, followed by unstable hemodynamic status, hypotension (46/
20 mmHg), tachycardia (121 beats/minute), low oxygen saturation
(85%), tachypnea (32 breaths/minute), hypoxemia, and respiratory
alkalosis. Endotracheal tube insertion was performed for impend-
ing respiratory failure. An immediate electrocardiogram showed
sinus tachycardia with an SIQ III TIII pattern (Fig. 1), suggestive of
PE. The echocardiogram showed a left ventricle ejection fraction of
32.7%, pulmonary arterial hypertension, and right heart dilatation.
Cardiopulmonary resuscitation was performed for 10 minutes
because of pulseless electrical activity. Because of acute right heart
failure, venoarterial ECMO system was initiated. Multidetector
chest computed tomography (CT) was arranged after stabilizing the
patient's hemodynamic status, which revealed a ﬁlling defect in the
pulmonary trunk before the right and left pulmonary arteries
(Fig. 2). Massive PE was diagnosed and emergent catheter-directed
thrombectomy was performed, followed by continuous low mo-
lecular weight heparin (LMWH) infusion.
After 5 days of heparin treatment, the patient presented with
abdominal distension and pain. The bedside ultrasonography
revealed massive ascites. Abdominal CT revealed internal bleeding
with hemoperitoneum in the left pelvic region. Heparin infusion
was stopped temporarily, and an emergent transcatheter arterial
embolization of the left uterine artery was performed. We removedby Elsevier Taiwan LLC. All rights reserved.
Fig. 1. The electrocardiogram of the patient demonstrates an SI QIII TIII pattern, in which an S wave is seen in lead I (hollow arrowhead), a Q wave in lead III (arrow), and inverted T
waves in lead III (arrowhead).
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substituted the heparin infusion for enoxaparin and warfarin.
Extubation was performed on the 8th day. Screening for inherited
thrombophilia during admission revealed 107% antithrombin III,
40% protein C, and 21.2% protein S.
The patient recovered quickly after extubation. Once in a stable
condition and the wound was healing sufﬁciently, she was trans-
ferred to a general ward for observation. The patient made a full
recovery without developing any neurological sequelae.
PE is difﬁcult to diagnose. Clinical signs and symptoms include
sustained hypotension, dyspnea, chest pain, tachycardia, and
tachypnea. Severe cases of PE can lead to cardiogenic shock, car-
diopulmonary arrest, and sudden death. Determination of PE
symptoms such as chest pain and shortness of breath from normal
physiological changes brought about by pregnancy should be made
with caution to avoid fatal misdiagnosis.
Amniotic ﬂuid embolism (AFE) is deﬁned as the passage of
amniotic ﬂuid into the maternal bloodstream to trigger an allergicFig. 2. Computed tomographic (CT) scan of the patient showing a ﬁlling defect within
the pulmonary trunk, right and left pulmonary arteries, left superior and inferior
pulmonary arteries, and right inferior pulmonary artery.reaction. The United Kingdom Amniotic Fluid Embolism Register
recommends the following entry criteria for suspected AFE: acute
hypotension, acute hypoxia, and coagulopathy or severe hemor-
rhage, all of which occur during labor, cesarean delivery, or within
30 minutes postpartum, and in the absence of other explanations
[5]. The management of AFE is resuscitative. In critically ill patients
with acute respiratory distress syndrome or cardiopulmonary
failure, use of aggressive management such as the ECMO system for
cardiovascular and respiratory support has been reported [6].
Pulmonary thromboembolism and AFE are responsible for
approximately 20% of perinatal maternal mortality in the United
States [1,7]. The differential diagnosis of these conditions is critical
to a successful outcome because they should be managed differ-
ently. The management of AFE is supportive and focuses on early
recognition, rapid cardiopulmonary stabilization, and adequate
oxygenation. In patients with suspected thromboembolism, treat-
ment with LMWH, unfractionated heparin (UFH), and thrombolytic
therapy should be started immediately to reduce mortality [8].
The diagnosis of acute pulmonary thromboembolism remains a
challenge to clinical physicians because the signs and symptoms
vary widely, from asymptomatic conditions to sustained hypoten-
sion and cardiopulmonary arrest. The diagnostic workup consists of
a clinical probability assessment, the D-dimer test, echocardiogra-
phy, venous ultrasonography, multidetector CT, and a ven-
tilationeperfusion scan [3]. These surveys should be modiﬁed
according to the severity of the clinical presentation based on the
patients' hemodynamic status. In the initial assessment, patients
with suspected PE are categorized into low, intermediate, or high
clinical probability based on their Wells score [9].
Agnelli and Becattini [10] suggested that, for hemodynamically
stable patients with a low or intermediate clinical probability of PE,
a normal D-dimer result indicates a low probability of PE, and
clinical exclusion from further investigation is recommended. In
patients with a high clinical probability of PE or with an elevated D-
dimer level, multidetector CT should be considered. Agnelli and
Becattini [10] also suggested a ventilationeperfusion scan as an
alternative if CT is unavailable or if CT is contraindicated for the
patient. However, the European Association of Nuclear Medicine
currently recommends a ventilationeperfusion scan as the gold
standard for the diagnosis of PE [11]. In hemodynamically unstable
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performed immediately because of its sensitivity in detecting
emboli in the main pulmonary arteries. If CT is not available or the
patient is critically ill, bedside echocardiography should be per-
formed to evaluate right ventricular function.
Because the patient in this case was hemodynamically unstable,
transport was unfeasible. According to Well's prediction rule, the
coexistence of tachycardia and recent surgery, and the fact that an
alternative diagnosis was less likely than PE, strongly supported PE
as the most probable diagnosis, and, thus, diagnostic imaging was
required for conﬁrmation [3,9]. Therefore, bedside echocardiogra-
phy was used to conﬁrm the presence of right ventricular dysfunc-
tion and to eliminate other possible causes of shock, such as
myocardial infarction, cardiac tamponade, and aortic dissection. The
ECMO systemwas applied to the patient as a supportive treatment
for the unstable hemodynamic status caused by acute right heart
failure because the patient had responded poorly tomedication and
cardiopulmonary resuscitation. The diagnosis of PE was conﬁrmed
by detecting thromboemboli in the main pulmonary arteries using
multidetector CTafter stabilizing the patient's hemodynamic status.
PE can be divided into massive, submassive, and low-risk PE. A
massive PE is characterized by acute PE with sustained hypotension
(systolic blood pressure <90 mmHg), pulselessness, or persistent
profound bradycardia (heart rate <40 bpm). A submassive PE is
characterized by either right ventricular dysfunction or myocardial
necrosis without systemic hypotension. A low-risk PE is neither
massive nor submassive [12]. In patients with suspected pulmonary
thromboembolism, immediate therapeutic anticoagulation should
be initiated, followed by long-term treatment with vitamin K
antagonist aiming for a target prothrombin time/international
normalized ratio of 2e3 for 6e12 weeks [13]. The ﬁrst-line treat-
ment of acute pulmonary thromboembolism includes LMWHs,
fondaparinux, and UFH. These anticoagulants should be continued
throughout pregnancy and for 6 weekse6 months postpartum
[12,14]. LMWHs (enoxaparin: 1 mg/kg every 12 hours or 1.5 mg/kg
daily) and fondaparinux (5e7.5mgdaily) are easier to use compared
to UFH (intravenous bolus of 333 IU/kg followed by an infusion of
250 IU/kg every 12 hours, adjusted according to the target-activated
partial thromboplastin timedi.e., 1.5e2.5 times the normal value)
[13]. UFH is preferred for the treatment of patientswith renal failure
because LMWHs and fondaparinux are excreted by the kidneys [8].
Patients with a single prior episode of PE have a risk of recur-
rence. The recurrence risk was found to be twice as high in patients
with thrombophilia. Inherited thrombophilias such as protein C
and protein S deﬁciencies may play an important role in causing PE
and its recurrence [15]. Screening for thrombophilia should be
performed 4e6 weeks after completion of anticoagulation. In our
case, we will screen our patient for inherited thrombophilia (anti-
thrombin III, protein C, protein S) and acquired thrombophilia
(antiphospholipid syndrome, lupus anticoagulant) 4e6 weeks after
completing the treatment with oral anticoagulants.
Thrombolytic therapy is recommended in patients with massive
and submassive PE who have a low risk of bleeding [12]. Available
thrombolytic drugs include streptokinase (250,000 IU IV bolus
followed by 100,000 IU/hour infusion for 12e24 hours), urokinase
(4400 IU/kg bolus followed by 4400 IU/kg/hour for 12e24 hours),
and alteplase (100 mg IV infusion over 2 hours) [12]. There is no
difference in efﬁcacy between the various thrombolytic agents.
However, streptokinase should be avoided in patients who have
received it previously because of the likely presence of neutrali-
zation antibodies [16]. A recent surgery or trauma is a contraindi-
cation to thrombolysis because of the increased risk of bleeding
complications. According to the American Heart Association,
catheter-directed embolectomy and fragmentation is suggested in
patients with massive PE who have contraindication tothrombolysis or who remain hemodynamically unstable after
receiving thrombolysis [10,12]. A recent meta-analysis of a case
series demonstrated that catheter-directed therapy had a clinical
success rate of 86% in the treatment of massive PE [17]. The patient
in our case received an emergent catheter-directed thrombectomy
after being diagnosed with massive PE. However, the procedure
was not satisfactorily effective. Anticoagulant was maintained at a
dosage designed to keep the activated partial thromboplastin time
at 1.5e2 times the control value. Internal bleeding developed 5 days
after heparin use, which was immediately controlled through
transcatheter arterial embolization.
The diagnosis and management of PE have been discussed
extensively. As previously mentioned, early recognition of PE and
early identiﬁcation of patients who are to be treated with antico-
agulants are the keys to a successful outcome.We conclude that, for
patients with suspected PE, treatment with anticoagulants should
start immediately and continue until the diagnosis of throm-
boemblism is eliminated [8]. For our patient, the ECMO system
decompressed the acutely overloaded right heart and maintained
hemodynamic stability. This demonstrates that such patients can
be rapidly treated and successfully supported by the ECMO system
while awaiting a deﬁnitive diagnosis.
Conﬂicts of interest
The authors declare no conﬂict of interest.
References
[1] Clark SL, Belfort MA, Dildy GA, Herbst MA, Meyers JA, Hankins GD. Maternal
death in the 21st century: causes, prevention, and relationship to cesarean
delivery. Am J Obstet Gynecol 2008;199:36.e1e5.
[2] Morris JM, Algert CS, Roberts CL. Incidence and risk factors for pulmonary
embolism in the postpartum period. J Thromb Haemost 2010;8:998e1003.
[3] Cutts BA, Dasgupta D, Hunt BJ. New directions in the diagnosis and treatment
of pulmonary embolism in pregnancy. Am J Obstet Gynecol 2012;208:102e8.
[4] Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism.
Circulation 2006;113:577e82.
[5] Tuffnell DJ. United Kingdom amniotic ﬂuid embolism register. BJOG 2005;112:
1625e9.
[6] Ho CH, Chen KB, Liu SK, Liu YF, Cheng HC, Wu RSC. Early application of
extracorporeal membrane oxygenation in a patient with amniotic ﬂuid em-
bolism. Acta Anaesthesiol Taiwan 2009;47:99e102.
[7] Berg CJ, Callaghan WM, Henderson Z, Syverson C. Pregnancy-related mortality
in the United States, 1998 to 2005. Obstet Gynecol 2010;116:1302e9.
[8] Bourjeily G, Paidas M, Khalil H, Rosene-Montella K, Rodger M. Pulmonary
embolism in pregnancy. Lancet 2010;375:500e12.
[9] Wells PS, Ginsberg JS, Anderson DR, Kearon C, Gent M, Turpie AG, et al. Use of
a clinical model for safe management of patients with suspected pulmonary
embolism. Ann Intern Med 1998;129:997e1005.
[10] Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med 2010;363:
266e74.
[11] Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B. EANM
guidelines for ventilation/perfusion scintigraphy: Part 1. Pulmonary imaging
with ventilation/perfusion single photon emission tomography. Eur J Nucl
Med Mol Imaging 2009;36:1356e70.
[12] Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ,
et al. Management of massive and submassive pulmonary embolism, iliofe-
moral deep vein thrombosis, and chronic thromboembolic pulmonary hy-
pertension: a scientiﬁc statement from the American Heart Association.
Circulation 2011;123:1788e830.
[13] Cushman M, Lim W, Zakai NA. Clinical practice guide on anticoagulant dosing
and management of anticoagulant-associated bleeding complications in
adults. Washington, DC: American Society of Hematology; 2011.
[14] Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism,
thrombophilia, antithrombotic therapy, and pregnancy. American College of
Chest Physicians evidence-based clinical practice guidelines. 8th ed. Chest
2008;133:844Se6S.
[15] TuranO, Ündar B, Günay T, Akkoçlu A. Investigation of inherited thrombophilias
in patients with pulmonary embolism. Blood Coagul Fibrinol 2013;24:140e9.
[16] Thomas MD, Chauhan A, More RS. Pulmonary embolismdan update on
thrombolytic therapy. QJM 2000;93:261e7.
[17] Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann LV. Catheter-
directed therapy for the treatment of massive pulmonary embolism: sys-
tematic review and meta-analysis of modern techniques. J Vasc Interv Radiol
2009;20:1431e40.
